Acadian Asset Management
HCAT icon

Acadian Asset Management’s Health Catalyst HCAT Stock Holding History

Acadian Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Sell
113,190
-819,525
-88% -$1.54M ﹤0.01% 1672
2025
Q4 		$2.23M Sell
932,715
-193,089
-17% -$528K ﹤0.01% 890
2025
Q3 		$3.21M Sell
1,125,804
-37,981
-3% -$130K 0.01% 766
2025
Q2 		$4.38M Buy
1,163,785
+233,556
+25% +$919K 0.01% 621
2025
Q1 		$4.21M Buy
930,229
+437,536
+89% +$2.32M 0.01% 551
2024
Q4 		$3.48M Buy
492,693
+15,426
+3% +$123K 0.01% 621
2024
Q3 		$3.88M Sell
477,267
-256,990
-35% -$1.86M 0.01% 565
2024
Q2 		$4.69M Buy
734,257
+9,697
+1% +$62.2K 0.01% 517
2024
Q1 		$5.45M Buy
724,560
+200,494
+38% +$1.83M 0.02% 449
2023
Q4 		$4.85M Buy
524,066
+358,670
+217% +$2.93M 0.02% 467
2023
Q3 		$1.67M Sell
165,396
-157,603
-49% -$1.88M 0.01% 739
2023
Q2 		$4.03M Buy
322,999
+184,175
+133% +$2.19M 0.02% 506
2023
Q1 		$1.61M Buy
138,824
+59,435
+75% +$758K 0.01% 767
2022
Q4 		$842K Buy
+79,389
New +$766K ﹤0.01% 892

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management's HCAT Position: Q1 2026 in Review

Acadian Asset Management reduced its Health Catalyst (HCAT) stake by 88% in Q1 2026, selling an estimated $1.54M and leaving 113,190 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Acadian Asset Management first reported a position in HCAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.45M in Q1 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Acadian Asset Management held 113,190 shares of Health Catalyst worth $142K as of Q1 2026.
  • Acadian Asset Management sold 819,525 Health Catalyst shares in Q1 2026, an estimated $1.54M.
  • Health Catalyst made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1672 holding.
  • Acadian Asset Management first reported a position in Health Catalyst in Q4 2022 and has held it in 14 quarters since.
  • Acadian Asset Management's Health Catalyst position peaked at $5.45M in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.